thromboembolism research hub

Randomised, crossover bioequivalence clinical trial of apixaban 5 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions

This study is testing if two versions of a blood-thinning medicine called apixaban (often known as Eliquis) work the same way in healthy people. Researchers want to ensure the body absorbs both medicines in a similar fashion. It's an early-stage study to check drug absorption.